Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.
about
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesWhole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemiaThe biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemiaIdentifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without ImmunotherapyChromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.Conditional immortalization of human B cells by CD40 ligation.Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks.Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we goClinical laboratory analysis of immunoglobulin heavy chain variable region genes for chronic lymphocytic leukemia prognosis.Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignanciesmiRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.How I treat CLL up front.Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) StudyComprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH)Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate.Biological evaluation of CpG stimulation of normal human B-cells: implications for B-cell biology and cytogenetic analysis of CLL B-cellsA pathobiological role of the insulin receptor in chronic lymphocytic leukemia.Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia.Update on risk-stratified management for chronic lymphocytic leukemia.Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.Genomic complexity identifies patients with aggressive chronic lymphocytic leukemiaThe role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia.Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responsesMolecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implications.Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemiaClinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia.t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: Report of two cases and a literature review.Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia.High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.Diagnostic techniques and therapeutic challenges in patients with TP53 dysfunctional chronic lymphocytic leukemia.Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application.Murine model of CD40-activation of B cells.Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia.Chronic lymphocytic leukemia: Time to go past genomics?
P2860
Q24616084-A373ADF9-F607-4A07-B48F-EAB973D68DD6Q24642439-72BD244F-627E-407E-8F8C-685CB83F7C50Q27024411-E059607F-7636-47C5-B122-9BD3A26CBA71Q28077136-30058716-F4E0-4FF4-ABF2-2ADD1FE2585AQ30685440-BED3E5A8-46A1-4BA0-AF8A-42B6F4558471Q33316020-5B2043CE-529D-42E2-B402-E6D2C974743AQ33567169-F48D7CB3-4B29-46D1-BDCC-3EBAB8CCCF6EQ33638819-4761DE12-0299-4201-B0FE-93D5FEEF4E30Q33744997-25A9EE1C-0DA1-46AB-95ED-B960CB81C24EQ33856248-3610FF14-A90D-4708-85C4-CF1C51FD625AQ34056568-B6C0954E-7494-4155-921A-54AE4D5908A7Q34062347-865F0EB4-24BB-4FE8-A76D-D76FA506164DQ34079123-81E0449C-9267-4506-9D84-D0961394B4CFQ34137158-D9C1328F-4B9C-4302-9F34-4AB01113567CQ34479465-14AE5621-D645-4EB6-AD99-49F034C7AEB7Q34586721-2CAB2075-8B87-4B59-BA8C-0C62E1E536B6Q34777365-23D58E58-494D-4B84-8043-0111132419CFQ34790995-8B5EDCCE-1CD7-42FF-98AA-6324DEC75F18Q34917625-3855D50F-7649-4CF2-993E-A8B0E22E4C6FQ35220403-98F4024E-6AD2-45AE-8200-D20462629B33Q35824945-AB01B074-4A95-4B8D-AC69-6DEA90C46D0DQ36634599-7C48054F-05A2-4FA7-9010-D6E3CC7D0DE5Q36651908-0FD02C30-B01A-4B0B-8714-FEEE02E42BE1Q36843780-99E8EBC9-FEE4-4BB9-8004-11B9640C22E6Q36849336-07E63AD5-8A41-485D-A0A5-0162BA152BD0Q36862542-8DF9CE6F-16A5-4544-AEF3-63CB57594515Q37104775-BFB8E418-04C0-4A28-9846-E80FC5314E69Q37152757-4BAA7159-0A5E-418D-BD9A-93BE76051C6CQ37257024-EF2D3ADB-F9CB-4D98-BBD0-8B83B286DDEFQ37273662-53BBD8F0-19B2-4ABB-B629-D45BD8AB925EQ37582234-8B1ADFDE-F4CF-4540-B9DC-E9BA96C3C6DAQ37588785-EE7B5492-786E-45A9-875B-6FBAE8D5CA09Q37810096-6BDAED2D-61F2-4CEB-BA81-08DF1675FEA2Q38003163-B06A78C2-7EC9-466C-9CB2-54E48A4D69DFQ38008448-6D0BA87C-0DDE-4E5F-82D1-5B0089786E0CQ38088354-9C28C31C-7214-47DF-9C05-921580EFE2A4Q38113268-A48268F6-367E-4C4D-827C-650A9F0EC48DQ38332142-E5F3B75A-CCAC-485E-8D0E-2FD55400FA38Q38612097-DCF60718-8D50-4452-AD06-6615B6766068Q38708220-6631DA3D-D819-45FD-B09E-491A115A7739
P2860
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Chromosomal translocations are ...... chronic lymphocytic leukemia.
@en
Chromosomal translocations are ...... chronic lymphocytic leukemia.
@nl
type
label
Chromosomal translocations are ...... chronic lymphocytic leukemia.
@en
Chromosomal translocations are ...... chronic lymphocytic leukemia.
@nl
prefLabel
Chromosomal translocations are ...... chronic lymphocytic leukemia.
@en
Chromosomal translocations are ...... chronic lymphocytic leukemia.
@nl
P2093
P1433
P1476
Chromosomal translocations are ...... chronic lymphocytic leukemia.
@en
P2093
Christine Mayr
Clemens-Martin Wendtner
David M Kofler
John Strehl
Raymonde Busch
Raymund Buhmann
P304
P356
10.1182/BLOOD-2005-05-2093
P407
P577
2005-09-22T00:00:00Z